Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

  1. López-Huertas, M.R.
  2. Gutiérrez, C.
  3. Madrid-Elena, N.
  4. Hernández-Novoa, B.
  5. Olalla-Sierra, J.
  6. Plana, M.
  7. Delgado, R.
  8. Rubio, R.
  9. Muñoz-Fernández, M.Á.
  10. Moreno, S.
Aldizkaria:
Scientific Reports

ISSN: 2045-2322

Argitalpen urtea: 2020

Alea: 10

Zenbakia: 1

Mota: Artikulua

DOI: 10.1038/S41598-020-79002-W GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus